SAN DIEGO, CA / ACCESSWIRE / November 11, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

The company now expects its annual 2024 revenue to grow between 20% and 21%, up from its previous forecast of 16% to 19% ...

The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in ...

PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.

PORTLAND, GA, UNITED STATES, November 5, 2024 /EINPresswire / -- The global Implantable Insulin Pump Market was pegged at $2.67 billion in 2020, and is estimated to reach $6.44 billion by 2030, ...

MONTRÉAL, Nov. 7, 2024 /CNW/ - Ypsomed and CamDiab are pleased to announce the approval of mylife YpsoPump insulin pump and ...

Insulet has launched the Omnipod 5 automated insulin delivery app for iPhone in the US. The app obviates the need for ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

On Sunday, during November's Diabetes Awareness Month, over 1,500 San Diegans walked to raise money to find a cure at the ...

and commercializes technology solutions for people living with diabetes in the United States and internationally. The company ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

The water bottles decorated with stickers promoting Diabetes Awareness Month and bracelets that the youngsters acquired for ...